A Trial of Adjuvant Therapy After Hepatocarcinoma Resection Based on Folate Receptor-positive Circulating Tumor Cells

NCT04521491 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

184

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: FOLFOX4(infusional fluorouracil [FU], leucovorin [LV], and oxaliplatin [OXA]).

Sponsor

Eastern Hepatobiliary Surgery Hospital